XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.2
SHARE-BASED COMPENSATION - Summary of Stock Option and Restricted Stock Activity (Details) - Employee Stock Option - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Jul. 02, 2023
Jul. 02, 2023
Sep. 25, 2022
Jan. 01, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Beginning number of shares, outstanding (in shares)   821,679    
Issued (in shares)   22,970    
Exercised (in shared)   (4,800)    
Forfeited / Canceled (in shares) (8,000)      
Number of shares, outstanding (in shares) 831,849 831,849    
Ending number of shares, options exercisable 577,128 577,128   573,863
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Weighted Average Exercise Price [Roll Forward]        
Beginning balance of options outstanding (in dollars per share)   $ 16.08    
Issued (in dollars per share)   11.84    
Forfeited / Canceled (in dollars per share) $ 11.91      
Ending balance of options outstanding (in dollars per share) 16.06 16.06    
Options exercisable at end of period $ 17.75 $ 17.75   $ 17.50
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Roll Forward]        
Options outstanding, weighted average remaining contractual term   6 years 1 month 6 days 6 years 4 months 24 days  
Optons exercisable, weighted average remaining contractual term   5 years 5 years 4 months 24 days  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Roll Forward]        
Beginning balance, intrinsic value   $ 1,907    
Ending value, intrinsic value $ 108 108    
Options exercisable, aggregate intrinsic value $ 108 $ 108   $ 1,164
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]        
Nonvested, number of shares 254,721 254,721   247,816
Nonvested options, weighted average grant date fair value $ 7.35 $ 7.35   $ 7.64
Exercised (in dollars per share)   $ 6.25